Willasch, Andre Manfred and Peters, Christina and Sedlacek, Petr and Dalle, Jean-Hugues and Kitra-Roussou, Vassiliki and Yesilipek, Akif and Wachowiak, Jacek and Lankester, Arjan and Prete, Arcangelo and Hamidieh, Amir Ali and Ifversen, Marianne and Buechner, Jochen and Krivan, Gergely and Hamladji, Rose-Marie and Diaz de Heredia, Cristina and Skoroboga-Tova, Elena and Michel, Gerard and Locatelli, Franco and Bertaina, Alice and Veys, Paul and Dupont, Sophie and Or, Reuven and Gungor, Tayfun and Aleinikova, Olga and Sufliarska, Sabina and Sundin, Mikael and Rascon, Jelena and Kaare, Ain and Nemet, Damir and Fagioli, Franca and Klingebiel, Thomas Erich and Styczynski, Jan and Bierings, Marc and Nagy, Kalman and Abecasis, Manuel and Afanasyev, Boris and Ansari, Marc and Venntenranta, Kim and Alseraihy, Amal and Chybicka, Alicja and Robinson, Stephen and Bertrand, Yves and Kupesiz, Alphan and Ghavamzadeh, Ardeshir and Campos, Antonio and Dalissier, Arnaud and Labopin, Myriam and Corbacioglu, Selim and Galimard, Jaques Emmanuel and Bader, Peter
(2019)
Myeloablative conditioning for first allogeneic HSCT in pediatric all: FTBI or chemotherapy? - An update of the retrospective multicenter EBMT-PDWP study.
BONE MARROW TRANSPLANTATION, 54.
pp. 137-138.
ISSN 0268-3369, 1476-5365
Full text not available from this repository.
Actions (login required)
 |
View Item |
